Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
42.44
+2.74 (6.90%)
Nov 20, 2024, 4:00 PM EST - Market closed

Harrow Revenue

Harrow had revenue of $49.26M in the quarter ending September 30, 2024, with 43.75% growth. This brings the company's revenue in the last twelve months to $169.14M, up 48.15% year-over-year. In the year 2023, Harrow had annual revenue of $130.19M with 46.95% growth.

Revenue (ttm)
$169.14M
Revenue Growth
+48.15%
P/S Ratio
8.92
Revenue / Employee
$536,946
Employees
315
Market Cap
1.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 202048.87M-2.29M-4.48%
Dec 31, 201951.17M9.79M23.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.59B
U.S. Physical Therapy 639.06M
Alphatec Holdings 572.74M
InMode 423.75M
BioCryst Pharmaceuticals 412.58M
Kiniksa Pharmaceuticals International, 384.10M
Certara 372.80M
Schrödinger 193.35M
Revenue Rankings